Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.

Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T; Parkinson's Progression Markers Initiative.

Ann Clin Transl Neurol. 2018 Oct 31;5(12):1460-1477. doi: 10.1002/acn3.644. eCollection 2018 Dec.

2.

Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.

Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K; Parkinson's Progression Marker Initiative*.

Mov Disord. 2018 May;33(5):771-782. doi: 10.1002/mds.27361. Epub 2018 Mar 23.

3.

Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.

Binney RJ, Pankov A, Marx G, He X, McKenna F, Staffaroni AM, Kornak J, Attygalle S, Boxer AL, Schuff N, Gorno-Tempini ML, Weiner MW, Kramer JH, Miller BL, Rosen HJ.

Brain Behav. 2017 Mar 23;7(4):e00675. doi: 10.1002/brb3.675. eCollection 2017 Apr.

4.

MR Vascular Fingerprinting in Stroke and Brain Tumors Models.

Lemasson B, Pannetier N, Coquery N, Boisserand LSB, Collomb N, Schuff N, Moseley M, Zaharchuk G, Barbier EL, Christen T.

Sci Rep. 2016 Nov 24;6:37071. doi: 10.1038/srep37071.

5.

Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.

Zhang Y, Wu IW, Tosun D, Foster E, Schuff N; Parkinson’s Progression Markers Initiative.

PLoS One. 2016 Oct 31;11(10):e0165540. doi: 10.1371/journal.pone.0165540. eCollection 2016.

6.

Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD.

Tosun D, Schuff N, Rabinovici GD, Ayakta N, Miller BL, Jagust W, Kramer J, Weiner MM, Rosen HJ.

Ann Clin Transl Neurol. 2016 Aug 30;3(10):740-751. eCollection 2016 Oct.

7.

Progression of brain atrophy in PSP and CBS over 6 months and 1 year.

Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, Schuff N, Rabinovici GD, Kramer JH, Jack CR Jr, Miller BL, Rosen HJ, Boxer AL; AL-108-231 investigators.

Neurology. 2016 Nov 8;87(19):2016-2025. Epub 2016 Oct 14.

8.

Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration.

Pankov A, Binney RJ, Staffaroni AM, Kornak J, Attygalle S, Schuff N, Weiner MW, Kramer JH, Dickerson BC, Miller BL, Rosen HJ.

Neuroimage Clin. 2015 Aug 18;12:332-40. doi: 10.1016/j.nicl.2015.08.002. eCollection 2016.

9.

Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study.

Zhang Y, Walter R, Ng P, Luong PN, Dutt S, Heuer H, Rojas-Rodriguez JC, Tsai R, Litvan I, Dickerson BC, Tartaglia MC, Rabinovici G, Miller BL, Rosen HJ, Schuff N, Boxer AL.

PLoS One. 2016 Jun 16;11(6):e0157218. doi: 10.1371/journal.pone.0157218. eCollection 2016.

10.

Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.

Tosun D, Schuff N, Jagust W, Weiner MW; Alzheimer''s Disease Neuroimaging Initiative.

Neurodegener Dis. 2016;16(1-2):87-94. doi: 10.1159/000439257. Epub 2015 Nov 12.

11.

Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.

Teipel S, Drzezga A, Grothe MJ, Barthel H, Chételat G, Schuff N, Skudlarski P, Cavedo E, Frisoni GB, Hoffmann W, Thyrian JR, Fox C, Minoshima S, Sabri O, Fellgiebel A.

Lancet Neurol. 2015 Oct;14(10):1037-53. doi: 10.1016/S1474-4422(15)00093-9. Epub 2015 Aug 26. Review.

PMID:
26318837
12.

Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.

Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K.

Mov Disord. 2015 Dec;30(14):1885-92. doi: 10.1002/mds.26325. Epub 2015 Aug 11.

PMID:
26260437
13.

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.

Jack CR Jr, Barnes J, Bernstein MA, Borowski BJ, Brewer J, Clegg S, Dale AM, Carmichael O, Ching C, DeCarli C, Desikan RS, Fennema-Notestine C, Fjell AM, Fletcher E, Fox NC, Gunter J, Gutman BA, Holland D, Hua X, Insel P, Kantarci K, Killiany RJ, Krueger G, Leung KK, Mackin S, Maillard P, Malone IB, Mattsson N, McEvoy L, Modat M, Mueller S, Nosheny R, Ourselin S, Schuff N, Senjem ML, Simonson A, Thompson PM, Rettmann D, Vemuri P, Walhovd K, Zhao Y, Zuk S, Weiner M.

Alzheimers Dement. 2015 Jul;11(7):740-56. doi: 10.1016/j.jalz.2015.05.002.

14.

Amyloid in dementia associated with familial FTLD: not an innocent bystander.

Naasan G, Rabinovici GD, Ghosh P, Elofson JD, Miller BL, Coppola G, Karydas A, Fong J, Perry D, Lee SE, Yokoyama JS, Seeley WW, Kramer JH, Weiner MW, Schuff N, Jagust WJ, Grinberg LT, Pribadi M, Yang Z, Sears R, Klein E, Wojta K, Rosen HJ.

Neurocase. 2016;22(1):76-83. doi: 10.1080/13554794.2015.1046458. Epub 2015 Jun 4.

15.

Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.

Zhang Y, Wu IW, Buckley S, Coffey CS, Foster E, Mendick S, Seibyl J, Schuff N.

Mov Disord. 2015 Aug;30(9):1229-36. doi: 10.1002/mds.26251. Epub 2015 Apr 29.

16.

Directed network motifs in Alzheimer's disease and mild cognitive impairment.

Friedman EJ, Young K, Tremper G, Liang J, Landsberg AS, Schuff N; Alzheimer's Disease Neuroimaging Initiative.

PLoS One. 2015 Apr 16;10(4):e0124453. doi: 10.1371/journal.pone.0124453. eCollection 2015.

17.

Bayesian segmentation of brainstem structures in MRI.

Iglesias JE, Van Leemput K, Bhatt P, Casillas C, Dutt S, Schuff N, Truran-Sacrey D, Boxer A, Fischl B; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jun;113:184-95. doi: 10.1016/j.neuroimage.2015.02.065. Epub 2015 Mar 14.

18.

Quantitative framework for prospective motion correction evaluation.

Pannetier NA, Stavrinos T, Ng P, Herbst M, Zaitsev M, Young K, Matson G, Schuff N.

Magn Reson Med. 2016 Feb;75(2):810-6. doi: 10.1002/mrm.25580. Epub 2015 Mar 11.

19.

A fast algorithm for denoising magnitude diffusion-weighted images with rank and edge constraints.

Lam F, Liu D, Song Z, Schuff N, Liang ZP.

Magn Reson Med. 2016 Jan;75(1):433-40. doi: 10.1002/mrm.25643. Epub 2015 Mar 2.

20.

Sensitive measures of executive dysfunction in non-demented Parkinson's disease.

Bott NT, Johnson ET, Schuff N, Galifianakis N, Subas T, Pollock J, Pressman P, Kramer JH, Possin KL.

Parkinsonism Relat Disord. 2014 Dec;20(12):1430-3. doi: 10.1016/j.parkreldis.2014.10.007. Epub 2014 Oct 15.

21.

Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment.

Nosheny RL, Insel PS, Truran D, Schuff N, Jack CR Jr, Aisen PS, Shaw LM, Trojanowski JQ, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2015 Jan;36(1):273-82. doi: 10.1016/j.neurobiolaging.2014.07.036. Epub 2014 Aug 1.

22.

Directed progression brain networks in Alzheimer's disease: properties and classification.

Friedman EJ, Young K, Asif D, Jutla I, Liang M, Wilson S, Landsberg AS, Schuff N; Alzheimer’s Disease Neuroimaging Initiative.

Brain Connect. 2014 Jun;4(5):384-93. doi: 10.1089/brain.2014.0235.

23.

Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2014 May;137(Pt 5):1550-61. doi: 10.1093/brain/awu043. Epub 2014 Mar 12.

24.

MR vascular fingerprinting: A new approach to compute cerebral blood volume, mean vessel radius, and oxygenation maps in the human brain.

Christen T, Pannetier NA, Ni WW, Qiu D, Moseley ME, Schuff N, Zaharchuk G.

Neuroimage. 2014 Apr 1;89:262-70. doi: 10.1016/j.neuroimage.2013.11.052. Epub 2013 Dec 7.

25.

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects.

Ewers M, Brendel M, Rizk-Jackson A, Rominger A, Bartenstein P, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neuroimage Clin. 2013 Nov 4;4:45-52. doi: 10.1016/j.nicl.2013.10.018. eCollection 2014.

26.

Numerical modeling of susceptibility-related MR signal dephasing with vessel size measurement: phantom validation at 3T.

Pannetier NA, Sohlin M, Christen T, Schad L, Schuff N.

Magn Reson Med. 2014 Sep;72(3):646-58. doi: 10.1002/mrm.24968. Epub 2013 Oct 24.

27.

Locally linear embedding (LLE) for MRI based Alzheimer's disease classification.

Liu X, Tosun D, Weiner MW, Schuff N; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2013 Dec;83:148-57. doi: 10.1016/j.neuroimage.2013.06.033. Epub 2013 Jun 21.

28.

MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements.

Zhang Y, Schuff N, Camacho M, Chao LL, Fletcher TP, Yaffe K, Woolley SC, Madison C, Rosen HJ, Miller BL, Weiner MW.

PLoS One. 2013 Jun 6;8(6):e66367. doi: 10.1371/journal.pone.0066367. Print 2013.

29.

Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease.

Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM.

JAMA Neurol. 2013 Mar 1;70(3):320-5.

30.

Denoising diffusion-weighted magnitude MR images using rank and edge constraints.

Lam F, Babacan SD, Haldar JP, Weiner MW, Schuff N, Liang ZP.

Magn Reson Med. 2014 Mar;71(3):1272-84. doi: 10.1002/mrm.24728.

31.

Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response.

Mackin RS, Tosun D, Mueller SG, Lee JY, Insel P, Schuff N, Truran-Sacrey D, Arean P, Nelson JC, Weiner MW.

Am J Geriatr Psychiatry. 2013 Aug;21(8):794-802. doi: 10.1016/j.jagp.2013.01.013. Epub 2013 Feb 6.

32.

The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment.

Mackin RS, Insel P, Tosun D, Mueller SG, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Lee JY, Jack CR Jr, Aisen PS, Petersen RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Am J Geriatr Psychiatry. 2013 Sep;21(9):906-14. doi: 10.1016/j.jagp.2013.01.021. Epub 2013 Feb 6.

33.

Voxel-wise co-analysis of macro- and microstructural brain alteration in mild cognitive impairment and Alzheimer's disease using anatomical and diffusion MRI.

Cardenas VA, Tosun D, Chao LL, Fletcher PT, Joshi S, Weiner MW, Schuff N.

J Neuroimaging. 2014 Sep-Oct;24(5):435-43. doi: 10.1111/jon.12002. Epub 2013 Feb 19.

34.

Voxelwise multivariate analysis of multimodality magnetic resonance imaging.

Naylor MG, Cardenas VA, Tosun D, Schuff N, Weiner M, Schwartzman A.

Hum Brain Mapp. 2014 Mar;35(3):831-46. doi: 10.1002/hbm.22217. Epub 2013 Feb 13.

35.

Standardization of analysis sets for reporting results from ADNI MRI data.

Wyman BT, Harvey DJ, Crawford K, Bernstein MA, Carmichael O, Cole PE, Crane PK, DeCarli C, Fox NC, Gunter JL, Hill D, Killiany RJ, Pachai C, Schwarz AJ, Schuff N, Senjem ML, Suhy J, Thompson PM, Weiner M, Jack CR Jr; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2013 May;9(3):332-7. doi: 10.1016/j.jalz.2012.06.004. Epub 2012 Oct 27.

36.

T2-based arterial spin labeling measurements of blood to tissue water transfer in human brain.

Gregori J, Schuff N, Kern R, Günther M.

J Magn Reson Imaging. 2013 Feb;37(2):332-42. doi: 10.1002/jmri.23822. Epub 2012 Sep 27.

37.

MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes.

Zhang Y, Tartaglia MC, Schuff N, Chiang GC, Ching C, Rosen HJ, Gorno-Tempini ML, Miller BL, Weiner MW.

J Alzheimers Dis. 2013;33(2):431-44. doi: 10.3233/JAD-2012-121156.

38.

Different associations of white matter lesions with depression and cognition.

Lee JY, Insel P, Mackin RS, Schuff N, Chui H, DeCarli C, Park KH, Mueller SG, Weiner MW.

BMC Neurol. 2012 Aug 25;12:83. doi: 10.1186/1471-2377-12-83.

39.

Improved diffusion imaging through SNR-enhancing joint reconstruction.

Haldar JP, Wedeen VJ, Nezamzadeh M, Dai G, Weiner MW, Schuff N, Liang ZP.

Magn Reson Med. 2013 Jan;69(1):277-89. doi: 10.1002/mrm.24229. Epub 2012 Mar 5.

40.

White matter alterations in cognitively normal apoE ε2 carriers: insight into Alzheimer resistance?

Chiang GC, Zhan W, Schuff N, Weiner MW.

AJNR Am J Neuroradiol. 2012 Aug;33(7):1392-7. doi: 10.3174/ajnr.A2984. Epub 2012 Mar 1.

41.

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, Murray SS, Sowell ER, Rimol LM, Mattingsdal M, Melle I, Agartz I, Andreassen OA, Schork NJ, Dale AM; Alzheimer's Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition, and Genetics Study, Weiner M, Aisen P, Petersen R, Jack CR Jr, Jagust W, Trojanowki JQ, Toga AW, Beckett L, Green RC, Saykin AJ, Morris J, Liu E, Montine T, Gamst A, Thomas RG, Donohue M, Walter S, Gessert D, Sather T, Harvey D, Kornak J, Dale A, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, DeCarli C, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, Mathis C, Cairns NJ, Taylor-Reinwald L, Trojanowki JQ, Shaw L, Lee VM, Korecka M, Crawford K, Neu S, Foroud TM, Potkin S, Shen L, Kachaturian Z, Frank R, Snyder PJ, Molchan S, Kaye J, Quinn J, Lind B, Dolen S, Schneider LS, Pawluczyk S, Spann BM, Brewer J, Vanderswag H, Heidebrink JL, Lord JL, Johnson K, Doody RS, Villanueva-Meyer J, Chowdhury M, Stern Y, Honig LS, Bell KL, Morris JC, Ances B, Carroll M, Leon S, Mintun MA, Schneider S, Marson D, Griffith R, Clark D, Grossman H, Mitsis E, Romirowsky A, deToledo-Morrell L, Shah RC, Duara R, Varon D, Roberts P, Albert M, Onyike C, Kielb S, Rusinek H, de Leon MJ, Glodzik L, De Santi S, Doraiswamy PM, Petrella JR, Coleman RE, Arnold SE, Karlawish JH, Wolk D, Smith CD, Jicha G, Hardy P, Lopez OL, Oakley M, Simpson DM, Porsteinsson AP, Goldstein BS, Martin K, Makino KM, Ismail MS, Brand C, Mulnard RA, Thai G, Mc-Adams-Ortiz C, Womack K, Mathews D, Quiceno M, Diaz-Arrastia R, King R, Weiner M, Martin-Cook K, DeVous M, Levey AI, Lah JJ, Cellar JS, Burns JM, Anderson HS, Swerdlow RH, Apostolova L, Lu PH, Bartzokis G, Silverman DH, Graff-Radford NR, Parfitt F, Johnson H, Farlow MR, Hake AM, Matthews BR, Herring S, van Dyck CH, Carson RE, MacAvoy MG, Chertkow H, Bergman H, Hosein C, Black S, Stefanovic B, Caldwell C, Ging-Yuek, Hsiung R, Feldman H, Mudge B, Assaly M, Kertesz A, Rogers J, Trost D, Bernick C, Munic D, Kerwin D, Mesulam MM, Lipowski K, Wu CK, Johnson N, Sadowsky C, Martinez W, Villena T, Turner RS, Johnson K, Reynolds B, Sperling RA, Johnson KA, Marshall G, Frey M, Yesavage J, Taylor JL, Lane B, Rosen A, Tinklenberg J, Sabbagh M, Belden C, Jacobson S, Kowall N, Killiany R, Budson AE, Norbash A, Johnson PL, Obisesan TO, Wolday S, Bwayo SK, Lerner A, Hudson L, Ogrocki P, Fletcher E, Carmichael O, Olichney J, Kittur S, Borrie M, Lee TY, Bartha R, Johnson S, Asthana S, Carlsson CM, Potkin SG, Preda A, Nguyen D, Tariot P, Fleisher A, Reeder S, Bates V, Capote H, Rainka M, Scharre DW, Kataki M, Zimmerman EA, Celmins D, Brown AD, Pearlson GD, Blank K, Anderson K, Santulli RB, Schwartz ES, Sink KM, Williamson JD, Garg P, Watkins F, Ott BR, Querfurth H, Tremont G, Salloway S, Malloy P, Correia S, Rosen HJ, Miller BL, Mintzer J, Longmire CF, Spicer K, Finger E, Rachinsky I, Drost D, Jernigan T, McCabe C, Grant E, Ernst T, Kuperman J, Chung Y, Murray S, Bloss C, Darst B, Pritchett L, Saito A, Amaral D, DiNino M, Eyngorina B, Sowell E, Houston S, Soderberg L, Kaufmann W, van Zijl P, Rizzo-Busack H, Javid M, Mehta N, Ruberry E, Powers A, Rosen B, Gebhard N, Manigan H, Frazier J, Kennedy D, Yakutis L, Hill M, Gruen J, Bosson-Heenan J, Carlson H.

Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3985-90. doi: 10.1073/pnas.1105829109. Epub 2012 Feb 16.

42.

Arterial spin labeling MRI study of age and gender effects on brain perfusion hemodynamics.

Liu Y, Zhu X, Feinberg D, Guenther M, Gregori J, Weiner MW, Schuff N.

Magn Reson Med. 2012 Sep;68(3):912-22. doi: 10.1002/mrm.23286. Epub 2011 Dec 2.

43.

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects.

Ewers M, Insel P, Jagust WJ, Shaw L, Trojanowski JQ, Aisen P, Petersen RC, Schuff N, Weiner MW; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Cereb Cortex. 2012 Sep;22(9):1993-2004. Epub 2011 Oct 29.

44.

MRI patterns of atrophy and hypoperfusion associations across brain regions in frontotemporal dementia.

Tosun D, Rosen H, Miller BL, Weiner MW, Schuff N.

Neuroimage. 2012 Feb 1;59(3):2098-109. doi: 10.1016/j.neuroimage.2011.10.031. Epub 2011 Oct 20.

45.

Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.

Tosun D, Schuff N, Shaw LM, Trojanowski JQ, Weiner MW; Alzheimer's Disease NeuroImaging Initiative.

J Alzheimers Dis. 2011;26 Suppl 3:77-90. doi: 10.3233/JAD-2011-0006.

46.

Imaging the Alzheimer brain.

Ashford JW, Salehi A, Furst A, Bayley P, Frisoni GB, Jack CR Jr, Sabri O, Adamson MM, Coburn KL, Olichney J, Schuff N, Spielman D, Edland SD, Black S, Rosen A, Kennedy D, Weiner M, Perry G.

J Alzheimers Dis. 2011;26 Suppl 3:1-27. doi: 10.3233/JAD-2011-0073. No abstract available.

47.

Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.

Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR Jr, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, Petersen RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2011 Sep;7(5):514-20. doi: 10.1016/j.jalz.2010.12.010.

48.

Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging.

Zhan W, Kang GA, Glass GA, Zhang Y, Shirley C, Millin R, Possin KL, Nezamzadeh M, Weiner MW, Marks WJ Jr, Schuff N.

Mov Disord. 2012 Jan;27(1):90-7. doi: 10.1002/mds.23917. Epub 2011 Aug 17.

49.

Joint assessment of structural, perfusion, and diffusion MRI in Alzheimer's disease and frontotemporal dementia.

Zhang Y, Schuff N, Ching C, Tosun D, Zhan W, Nezamzadeh M, Rosen HJ, Kramer JH, Gorno-Tempini ML, Miller BL, Weiner MW.

Int J Alzheimers Dis. 2011;2011:546871. doi: 10.4061/2011/546871. Epub 2011 Jun 27.

50.

Progression of white matter degeneration in amyotrophic lateral sclerosis: A diffusion tensor imaging study.

Zhang Y, Schuff N, Woolley SC, Chiang GC, Boreta L, Laxamana J, Katz JS, Weiner MW.

Amyotroph Lateral Scler. 2011 Nov;12(6):421-9. doi: 10.3109/17482968.2011.593036. Epub 2011 Jul 11.

Supplemental Content

Loading ...
Support Center